“…Despite the pharmaceutical importance of mitragynine and other indole and oxindole alkaloids produced in M. speciosa , the downstream steps of MIA biosynthesis in this species are only recently being uncovered . Other species of mitragyna, including M. hirsuta , M. rotundifolia , M. diversifolia , and M. parvifolia , are also used medicinally in various parts of the world to treat cough, hypertension, diarrhea, depression, fever, and pain. , These species accumulate either the oxindole alkaloid mitraphylline (Scheme ) or the MIA mitraciliatine, but none produce mitragynine, which is unique to M. speciosa . , The various species of mitragyna have historically been identified by either floral or fruit morphology and further differentiated by DNA barcoding using the nuclear ribosomal internal transcribed spacers ( ITS ) . There is wide variation in alkaloidal profiles even among various M. speciosa cultivars, including cultivars with low mitragynine content in addition to accumulating mitraphylline, an MIA characteristic of other mitragyna species. , Furthermore, quantitative characterization of MIAs in whole plants and developmental variation of MIAs have not been studied comprehensively in M. speciosa .…”